Pregnancy and neonatal outcomes after periconceptional exposure to isotretinoin in Koreans

OBJECTIVE: Isotretinoin should not be used during pregnancy because of the risk of birth defects. Most pregnant women exposed to isotretinoin choose voluntary pregnancy termination due to concerns about birth defects. However, birth outcome data supporting the termination of pregnancy are lacking. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Cha, Eun-Hwan, Kim, NaeRy, Kwak, Ho-Seok, Han, Hae Ji, Joo, Sung Hong, Choi, June-Seek, Chun, Kyoung-Chul, Kim, Young-Ah, Koh, Jae-Whoan, Han, Jung Yeol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Obstetrics and Gynecology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942757/
https://www.ncbi.nlm.nih.gov/pubmed/35193174
http://dx.doi.org/10.5468/ogs.21354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942757/
https://www.ncbi.nlm.nih.gov/pubmed/35193174
http://dx.doi.org/10.5468/ogs.21354

Ejemplares similares